Laura A. Maile
Departments of Medicine and Ophthalmology
School of Medicine
University of North Carolina at Chapel Hill
Chapel Hill
USA
Name/email consistency: high
- Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes. Maile, L.A., Gollahon, K., Wai, C., Byfield, G., Hartnett, M.E., Clemmons, D. Diabetologia (2012)
- An essential role for the association of CD47 to SHPS-1 in skeletal remodeling. Maile, L.A., Demambro, V.E., Wai, C., Aday, A.W., Capps, B.E., Beamer, W.G., Rosen, C.J., Clemmons, D.R. J. Bone Miner. Res. (2011)
- Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation. Maile, L.A., Allen, L.B., Hanzaker, C.F., Gollahon, K.A., Dunbar, P., Clemmons, D.R. Exp. Diabetes. Res (2010)
- Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo. Maile, L.A., Capps, B.E., Miller, E.C., Aday, A.W., Clemmons, D.R. Diabetes (2008)
- Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin. Maile, L.A., Aday, A.W., Busby, W.H., Sanghani, R., Veluvolu, U., Clemmons, D.R. J. Cell. Biochem. (2008)
- Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I. Maile, L.A., Capps, B.E., Miller, E.C., Allen, L.B., Veluvolu, U., Aday, A.W., Clemmons, D.R. Mol. Endocrinol. (2008)
- Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Maile, L.A., Capps, B.E., Ling, Y., Xi, G., Clemmons, D.R. Endocrinology (2007)
- Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Maile, L.A., Busby, W.H., Sitko, K., Capps, B.E., Sergent, T., Badley-Clarke, J., Clemmons, D.R. Mol. Endocrinol. (2006)
- The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Maile, L.A., Busby, W.H., Sitko, K., Capps, B.E., Sergent, T., Badley-Clarke, J., Ling, Y., Clemmons, D.R. Mol. Endocrinol. (2006)
- Endogenous IGFBP-3 is protected from inducible IGFBP-3 protease activity in normal adult serum. Maile, L.A., Whellams, E.J., Holly, J.M. Growth Horm. IGF Res. (2000)









